Publications

Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressant. S P Rossby, I Nalepa, M Huang, C Perrin, A M Burt, D E Schmidt, D D Gillespie, F Sulser
Brain research,
PMID:7583316
Thursday, 14 December 1995
Immunoreactivity of ageing C57BL female mice rendered tolerant to the H-Y antigen. A Skowron-Cendrzak, A Roman, V Holán, M Kubera, A Basta-Kaim
Folia biologica,
PMID:7589705
Thursday, 7 December 1995
Adenosine A2 receptors stimulate c-fos expression in striatal neurons of 6-hydroxydopamine-lesioned rats. M Morelli, A Pinna, J Wardas, G Di Chiara
Neuroscience,
PMID:7477908
Monday, 4 December 1995
The effect of interaction between (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R)-ACPD and noradrenaline on cyclic AMP accumulation: different actions in brain slices, primary glial and neuronal cell cultures. A Pilc, B Legutko, T Frankiewicz, A Czyrak
Polish journal of pharmacology,
PMID:7550553
Thursday, 9 November 1995
100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug. P Popik, R T Layer, P Skolnick
Pharmacological reviews,
PMID:7568327
Tuesday, 7 November 1995
Structure-activity relationship studies of CNS agents. XII. 1-[4-(4-aryl-1-piperazinyl)butyl]-3,4-dihydro-2(1H)-quinolinones: new 5-HT1A, 5-HT2 and D2 ligands with a potential antipsychotic activity. J L Mokrosz, E Chojnacka-Wójcik, A Dereń-Wesołek, A Kłodzińska, M Maćkowiak, Z Bielecka, M H Paluchowska
Drug design and discovery,
PMID:7548635
Monday, 6 November 1995
Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats. G Skuza, Z Rogoz, G Quack, W Danysz
Journal of neural transmission. General section,
PMID:7710739
Friday, 12 May 1995
mRNA distribution of two isoforms of somatostatin receptor 2 (mSSTR2A and mSSTR2B) in mouse brain. M Vanetti, B Ziólkowska, X Wang, G Horn, V Höllt
Brain research. Molecular brain research,
PMID:7877453
Thursday, 6 April 1995
Differential effects of CGP 37849 and MK-801, competitive and noncompetitive NMDA antagonists, with respect to the modulation of sensorimotor gating and dopamine outflow in the prefrontal cortex of rats. K Wedzony, K Gołembiowska, M Zazula
Naunyn-Schmiedeberg's archives of pharmacology,
PMID:7870195
Wednesday, 29 March 1995
The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex. P Popik, R T Layer, P Skolnick
Psychopharmacology,
PMID:7531855
Thursday, 16 March 1995